News
BULFINCH COMMITS TO CLOSING THE GENDER AND RACIAL WAGE GAP WITH BOSTON WOMEN’S WORKFORCE COUNCIL
Bulfinch Pledges the BWWC’s 100% Talent Compact Signer on National Equal Pay Day The Bulfinch Companies, Inc. (Bulfinch), a Boston-based private real estate investment, development and management firm, is pleased to announce a new partnership with the Boston…Read the Story
Bulfinch Leases over 40,000sf to Evolved By Nature in Needham
An affiliate of The Bulfinch Companies, Inc. (Bulfinch), a commercial real estate and investment firm, today announced a new long-term lease with Evolved By Nature, Inc. for 43,000+/- SF at 117 Kendrick Street in Needham, MA. Founded in…Read the Story
Bulfinch 2022 Year in Review Video
As we reflect on the past year, we would like to thank every member of The Bulfinch Team and our partners for contributing to the firm’s accomplishments. We look forward to continuing to collaborate and innovate in 2023! Special…Read the Story
BULFINCH RECEIVES BUILDING IMPACT AWARDS
Four Bulfinch properties recognized for their tenant engagement in volunteering events and community initiatives The Bulfinch Companies, Inc. (Bulfinch) a Boston-based private real estate investment, development and management firm announces four Bulfinch properties are recipients of 2022 Building Impact…Read the Story
Bulfinch Leases 17,000 SF to Xenon Pharmaceuticals
An affiliate of The Bulfinch Companies, Inc. (Bulfinch), a commercial real estate and investment firm, today announced a new lease with Xenon Pharmaceuticals, Inc. for 17,000 SF at 117 Kendrick Street in Needham, MA. Xenon Pharmaceuticals is a clinical…Read the Story
Bulfinch’s Mark DiOrio, Managing Director and General Counsel, Awarded Boston Real Estate Times’ Excellence in Commercial Real Estate Law 2022
The Bulfinch Companies, Inc. (Bulfinch), a private real estate investment, development and management firm, announces its Managing Director and General Counsel, Mark R. DiOrio, was awarded Boston Real Estate Times’ Excellence in Commercial Real Estate Law 2022 at…Read the Story